-
1
-
-
85019117181
-
International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue
-
Stel VS, Brück K, Fraser S, Zoccali C, Massy ZA, Jager KJ. International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue. Nephrol Dial Transplant. 2017; 32:ii129–ii135.
-
(2017)
Nephrol Dial Transplant
, vol.32
, pp. ii129-ii135
-
-
Stel, V.S.1
Brück, K.2
Fraser, S.3
Zoccali, C.4
Massy, Z.A.5
Jager, K.J.6
-
3
-
-
84860133754
-
Oxidative stress, anti-oxidant therapies and chronic kidney disease
-
Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology. 2012; 17:311–321.
-
(2012)
Nephrology
, vol.17
, pp. 311-321
-
-
Small, D.M.1
Coombes, J.S.2
Bennett, N.3
Johnson, D.W.4
Gobe, G.C.5
-
5
-
-
0042867413
-
Contribution of polyol pathway to diabetes-induced oxidative stress
-
Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephro. 2003; 14:S233–S236.
-
(2003)
J Am Soc Nephro
, vol.14
, pp. S233-S236
-
-
Chung, S.S.1
Ho, E.C.2
Lam, K.S.3
Chung, S.K.4
-
6
-
-
57049146797
-
Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
-
Cachofeiro V, Goicochea M, De Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 2008; 74:S4–S9.
-
(2008)
Kidney Int
, vol.74
, pp. S4-S9
-
-
Cachofeiro, V.1
Goicochea, M.2
De Vinuesa, S.G.3
Oubiña, P.4
Lahera, V.5
Luño, J.6
-
7
-
-
84991706010
-
Diabetes and Kidney Disease: role of Oxidative Stress
-
Jha JC, Banal C, Chow BS, Cooper ME, Jandeleit-Dahm K. Diabetes and Kidney Disease: role of Oxidative Stress. Antioxid Redox Signal. 2016; 25:657–684.
-
(2016)
Antioxid Redox Signal
, vol.25
, pp. 657-684
-
-
Jha, J.C.1
Banal, C.2
Chow, B.S.3
Cooper, M.E.4
Jandeleit-Dahm, K.5
-
8
-
-
78349297565
-
Oxidative stress and diabetic complications
-
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107:1058–1070.
-
(2010)
Circ Res
, vol.107
, pp. 1058-1070
-
-
Giacco, F.1
Brownlee, M.2
-
9
-
-
0019787519
-
Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis
-
Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Nat Acad Sci. 1981; 78:6858–6862.
-
(1981)
Proc Nat Acad Sci
, vol.78
, pp. 6858-6862
-
-
Ames, B.N.1
Cathcart, R.2
Schwiers, E.3
Hochstein, P.4
-
11
-
-
84964792189
-
Nox4 has a crucial role in uric acid-induced oxidative stress and apoptosis in renal tubular cells
-
Li Z, Sheng Y, Liu C, et al. Nox4 has a crucial role in uric acid-induced oxidative stress and apoptosis in renal tubular cells. Mol Med Rep. 2016; 13:4343–4348.
-
(2016)
Mol Med Rep
, vol.13
, pp. 4343-4348
-
-
Li, Z.1
Sheng, Y.2
Liu, C.3
-
12
-
-
79955640282
-
Challenges of conducting a trial of uric-acid-lowering therapy in CKD
-
Badve SV, Brown F, Hawley CM, et al. Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nat Rev Nephrol. 2011; 7:295–300.
-
(2011)
Nat Rev Nephrol
, vol.7
, pp. 295-300
-
-
Badve, S.V.1
Brown, F.2
Hawley, C.M.3
-
13
-
-
84896728958
-
Uric acid and chronic kidney disease: a time to act
-
Bellomo G. Uric acid and chronic kidney disease: a time to act? World J Nephrol. 2013; 2:17.
-
(2013)
World J Nephrol
, vol.2
, pp. 17
-
-
Bellomo, G.1
-
14
-
-
84859626188
-
New insights into uric acid effects on the progression and prognosis of chronic kidney disease
-
Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail. 2012; 34:510–520.
-
(2012)
Ren Fail
, vol.34
, pp. 510-520
-
-
Filiopoulos, V.1
Hadjiyannakos, D.2
Vlassopoulos, D.3
-
15
-
-
84880926698
-
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
-
Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013; 14:164.
-
(2013)
BMC Nephrol
, vol.14
, pp. 164
-
-
Gustafsson, D.1
Unwin, R.2
-
17
-
-
84882925526
-
Uric acid and chronic kidney disease: which is chasing which
-
Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang D-H, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant. 2013; 28:2221–2228.
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. 2221-2228
-
-
Johnson, R.J.1
Nakagawa, T.2
Jalal, D.3
Sánchez-Lozada, L.G.4
Kang, D.-H.5
Ritz, E.6
-
18
-
-
80054067462
-
Uric acid and chronic kidney disease: new understanding of an old problem
-
Elsevier
-
Kang D-H, Chen W. Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol. Elsevier, 2011; 31:447–452.
-
(2011)
Semin Nephrol
, vol.31
, pp. 447-452
-
-
Kang, D.-H.1
Chen, W.2
-
19
-
-
84901796917
-
The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship
-
Kim IY, Lee DW, Lee SB, Kwak IS. The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship. BioMed Res Int. 2014; 2014.
-
(2014)
BioMed Res Int
, vol.2014
-
-
Kim, I.Y.1
Lee, D.W.2
Lee, S.B.3
Kwak, I.S.4
-
20
-
-
0037386574
-
Glycated albumin increases oxidative stress, activates NF-κB and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-β 1 production in macrophage RAW cells
-
Cohen MP, Shea E, Chen S, Shearman CW. Glycated albumin increases oxidative stress, activates NF-κB and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-β 1 production in macrophage RAW cells. J Lab Clin Med. 2003; 141:242–249.
-
(2003)
J Lab Clin Med
, vol.141
, pp. 242-249
-
-
Cohen, M.P.1
Shea, E.2
Chen, S.3
Shearman, C.W.4
-
21
-
-
0026970404
-
Nuclear factor kB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)
-
Schreck R, Albermann K, Baeuerle PA. Nuclear factor kB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992; 17:221–237.
-
(1992)
Free Radic Res Commun
, vol.17
, pp. 221-237
-
-
Schreck, R.1
Albermann, K.2
Baeuerle, P.A.3
-
22
-
-
0035137324
-
Transcription factor-κB (NF-κB) and renal disease
-
Guijarro C, Egido J. Transcription factor-κB (NF-κB) and renal disease. Kidney Int. 2001; 59:415–424.
-
(2001)
Kidney Int
, vol.59
, pp. 415-424
-
-
Guijarro, C.1
Egido, J.2
-
24
-
-
44349155996
-
The cytokine TWEAK modulates renal tubulointerstitial inflammation
-
Sanz AB, Justo P, Sanchez-Niño MD, et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol. 2008; 19:695–703.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 695-703
-
-
Sanz, A.B.1
Justo, P.2
Sanchez-Niño, M.D.3
-
25
-
-
9144233521
-
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells
-
Verzola D, Bertolotto MB, Villaggio B, et al. Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells. J Am Soc Nephrol. 2004; 15:S85–S87.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. S85-S87
-
-
Verzola, D.1
Bertolotto, M.B.2
Villaggio, B.3
-
26
-
-
85042508947
-
Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB
-
Song IH, Jung KJ, Lee TJ, et al. Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB. Nephrology. 2017; https://doi.org/10.1111/nep.13047
-
(2017)
Nephrology
-
-
Song, I.H.1
Jung, K.J.2
Lee, T.J.3
-
27
-
-
78049370987
-
Oxidative stress, inflammation, and cancer: how are they linked
-
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010; 49:1603–1616.
-
(2010)
Free Radic Biol Med
, vol.49
, pp. 1603-1616
-
-
Reuter, S.1
Gupta, S.C.2
Chaturvedi, M.M.3
Aggarwal, B.B.4
-
28
-
-
84943339252
-
P53 contributes to cisplatin induced renal oxidative damage via regulating P66shc and MnSOD
-
Yuan Y, Wang H, Wu Y, et al. P53 contributes to cisplatin induced renal oxidative damage via regulating P66shc and MnSOD. Cell Physiol Biochem. 2015; 37:1240–1256.
-
(2015)
Cell Physiol Biochem
, vol.37
, pp. 1240-1256
-
-
Yuan, Y.1
Wang, H.2
Wu, Y.3
-
29
-
-
84962277779
-
The role of TGF-β1, P53 and microRNA 192 in the pathogenesis of diabetic nephropathy in diabetic rats
-
Liu Q, Jiao X, Chen B, Zhao W, Meng D. The role of TGF-β1, P53 and microRNA 192 in the pathogenesis of diabetic nephropathy in diabetic rats. Int J Clin Exp Med. 2016; 9:3139–3145.
-
(2016)
Int J Clin Exp Med
, vol.9
, pp. 3139-3145
-
-
Liu, Q.1
Jiao, X.2
Chen, B.3
Zhao, W.4
Meng, D.5
-
30
-
-
84891753843
-
AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose
-
Huang K, Huang J, Chen C, et al. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose. Cell Signal. 2014; 26:629–638.
-
(2014)
Cell Signal
, vol.26
, pp. 629-638
-
-
Huang, K.1
Huang, J.2
Chen, C.3
-
31
-
-
84920111614
-
Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy
-
Teng B, Duong M, Tossidou I, Yu X, Schiffer M. Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy. Front Endocrinol. 2014; 5:179.
-
(2014)
Front Endocrinol
, vol.5
, pp. 179
-
-
Teng, B.1
Duong, M.2
Tossidou, I.3
Yu, X.4
Schiffer, M.5
-
34
-
-
84882236393
-
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
-
Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013; 83:1029.
-
(2013)
Kidney Int
, vol.83
, pp. 1029
-
-
Ruiz, S.1
Pergola, P.E.2
Zager, R.A.3
Vaziri, N.D.4
-
35
-
-
84926322775
-
Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease
-
Tucker PS, Scanlan AT, Dalbo VJ. Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Oxid Med Cell Longev. 2015; 2015:806358.
-
(2015)
Oxid Med Cell Longev
, vol.2015
, pp. 806358
-
-
Tucker, P.S.1
Scanlan, A.T.2
Dalbo, V.J.3
-
36
-
-
33645509709
-
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation
-
Du X, Edelstein D, Obici S, Higham N, Zou M-H, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest. 2006; 116:1071.
-
(2006)
J Clin Invest
, vol.116
, pp. 1071
-
-
Du, X.1
Edelstein, D.2
Obici, S.3
Higham, N.4
Zou, M.-H.5
Brownlee, M.6
-
37
-
-
84900559310
-
Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation
-
Lin Q, Chen Y, Lv J, et al. Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation. Am J Physiol Renal Physiol. 2014; 306:F885–F895.
-
(2014)
Am J Physiol Renal Physiol
, vol.306
, pp. F885-F895
-
-
Lin, Q.1
Chen, Y.2
Lv, J.3
-
38
-
-
1942438654
-
Advanced glycation end-products and the progress of diabetic vascular complications
-
Jakuš V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res. 2004; 53:131–142.
-
(2004)
Physiol Res
, vol.53
, pp. 131-142
-
-
Jakuš, V.1
Rietbrock, N.2
-
39
-
-
42049118293
-
The role of advanced glycation end products in progression and complications of diabetes
-
Goh S-Y, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocr Metab. 2008; 93:1143–1152.
-
(2008)
J Clin Endocr Metab
, vol.93
, pp. 1143-1152
-
-
Goh, S.-Y.1
Cooper, M.E.2
-
40
-
-
84871912190
-
Advanced glycation end products: key players in skin aging
-
Gkogkolou P, Böhm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012; 4:259–270.
-
(2012)
Dermatoendocrinol
, vol.4
, pp. 259-270
-
-
Gkogkolou, P.1
Böhm, M.2
-
41
-
-
18244373458
-
Mechanisms, pathophysiology, and therapy of arterial stiffness
-
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005; 25:932–943.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 932-943
-
-
Zieman, S.J.1
Melenovsky, V.2
Kass, D.A.3
-
42
-
-
0027970304
-
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
-
Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Nat Acad Sci. 1994; 91:11704–11708.
-
(1994)
Proc Nat Acad Sci
, vol.91
, pp. 11704-11708
-
-
Vlassara, H.1
Striker, L.J.2
Teichberg, S.3
Fuh, H.4
Li, Y.M.5
Steffes, M.6
-
45
-
-
0037377697
-
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
-
Wendt TM, Tanji N, Guo J, et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol. 2003; 162:1123–1137.
-
(2003)
Am J Pathol
, vol.162
, pp. 1123-1137
-
-
Wendt, T.M.1
Tanji, N.2
Guo, J.3
-
46
-
-
0347360360
-
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
-
Flyvbjerg A, Denner L, Schrijvers BF, et al. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes. 2004; 53:166–172.
-
(2004)
Diabetes
, vol.53
, pp. 166-172
-
-
Flyvbjerg, A.1
Denner, L.2
Schrijvers, B.F.3
-
47
-
-
84875370568
-
Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update
-
Arora MK, Singh UK. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update. Vascul Pharmacol. 2013; 58:259–271.
-
(2013)
Vascul Pharmacol
, vol.58
, pp. 259-271
-
-
Arora, M.K.1
Singh, U.K.2
-
48
-
-
36048938456
-
A breakthrough in diabetic nephropathy: the role of endothelial dysfunction
-
Nakagawa T, Segal M, Croker B, Johnson RJ. A breakthrough in diabetic nephropathy: the role of endothelial dysfunction. Nephrol Dial Transplant. 2007; 22:2775–2777.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 2775-2777
-
-
Nakagawa, T.1
Segal, M.2
Croker, B.3
Johnson, R.J.4
-
49
-
-
85003726485
-
Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy
-
Thallas-Bonke V, Jha JC, Gray SP, et al. Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy. Physiol Rep. 2014; 2:e12192.
-
(2014)
Physiol Rep
, vol.2
-
-
Thallas-Bonke, V.1
Jha, J.C.2
Gray, S.P.3
-
50
-
-
7044231909
-
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α− dependent pathway
-
Thallas-Bonke V, Lindschau C, Rizkalla B, et al. Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α− dependent pathway. Diabetes. 2004; 53:2921–2930.
-
(2004)
Diabetes
, vol.53
, pp. 2921-2930
-
-
Thallas-Bonke, V.1
Lindschau, C.2
Rizkalla, B.3
-
51
-
-
0036086641
-
Mesangial cell protein kinase C isozyme activation in the diabetic milieu
-
Whiteside CI, Dlugosz JA. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol. 2002; 282:F975–F980.
-
(2002)
Am J Physiol Renal Physiol
, vol.282
, pp. F975-F980
-
-
Whiteside, C.I.1
Dlugosz, J.A.2
-
52
-
-
79751477368
-
A glimpse of various pathogenetic mechanisms of diabetic nephropathy
-
Kanwar YS, Sun L, Xie P, Liu F-y, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011; 6:395–423.
-
(2011)
Annu Rev Pathol
, vol.6
, pp. 395-423
-
-
Kanwar, Y.S.1
Sun, L.2
Xie, P.3
Liu, F.-Y.4
Chen, S.5
-
53
-
-
33845522286
-
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ-null mice
-
Ohshiro Y, Ma RC, Yasuda Y, et al. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ-null mice. Diabetes. 2006; 55:3112–3120.
-
(2006)
Diabetes
, vol.55
, pp. 3112-3120
-
-
Ohshiro, Y.1
Ma, R.C.2
Yasuda, Y.3
-
54
-
-
0029087910
-
Identification of the mechanism for the inhibition of Na+, K (+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2
-
Xia P, Kramer RM, King GL. Identification of the mechanism for the inhibition of Na+, K (+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest. 1995; 96:733.
-
(1995)
J Clin Invest
, vol.96
, pp. 733
-
-
Xia, P.1
Kramer, R.M.2
King, G.L.3
-
55
-
-
0034710891
-
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
-
Du X-L, Edelstein D, Rossetti L, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Nat Acad Sci. 2000; 97:12222–12226.
-
(2000)
Proc Nat Acad Sci
, vol.97
, pp. 12222-12226
-
-
Du, X.-L.1
Edelstein, D.2
Rossetti, L.3
-
56
-
-
85047691537
-
Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells
-
Du X, Matsumura T, Edelstein D, et al. Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest. 2003; 112:1049.
-
(2003)
J Clin Invest
, vol.112
, pp. 1049
-
-
Du, X.1
Matsumura, T.2
Edelstein, D.3
-
57
-
-
0035136240
-
Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation
-
Garcia Soriano F, Virag L, Jagtap P, et al. Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med. 2001; 7.
-
(2001)
Nat Med
, vol.7
-
-
Garcia Soriano, F.1
Virag, L.2
Jagtap, P.3
-
58
-
-
33845529318
-
Poly (ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice
-
Szabó C, Biser A, Benkő R, Böttinger E, Suszták K. Poly (ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes. 2006; 55:3004–3012.
-
(2006)
Diabetes
, vol.55
, pp. 3004-3012
-
-
Szabó, C.1
Biser, A.2
Benkő, R.3
Böttinger, E.4
Suszták, K.5
-
59
-
-
0033852661
-
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
-
Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int. 2000; 58:S13–S18.
-
(2000)
Kidney Int
, vol.58
, pp. S13-S18
-
-
Schleicher, E.D.1
Weigert, C.2
-
60
-
-
84990044586
-
Polyol pathway: A possible mechanism of diabetes complications in the eye
-
Mathebula SD. Polyol pathway: A possible mechanism of diabetes complications in the eye. Afr Vision Eye Health. 2015; 74:13.
-
(2015)
Afr Vision Eye Health
, vol.74
, pp. 13
-
-
Mathebula, S.D.1
-
61
-
-
20044376702
-
The pathobiology of diabetic complications
-
Brownlee M. The pathobiology of diabetic complications. Diabetes. 2005; 54:1615–1625.
-
(2005)
Diabetes
, vol.54
, pp. 1615-1625
-
-
Brownlee, M.1
-
62
-
-
0033857113
-
Aldose reductase and the role of the polyol pathway in diabetic nephropathy
-
Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. 2000; 58:S3–S12.
-
(2000)
Kidney Int
, vol.58
, pp. S3-S12
-
-
Dunlop, M.1
-
63
-
-
0032958288
-
Contributions of polyol pathway to oxidative stress in diabetic cataract
-
Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999; 13:23–30.
-
(1999)
FASEB J
, vol.13
, pp. 23-30
-
-
Lee, A.Y.1
Chung, S.S.2
-
64
-
-
10644277302
-
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
-
Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest. 2004; 34:785–796.
-
(2004)
Eur J Clin Invest
, vol.34
, pp. 785-796
-
-
Wolf, G.1
-
65
-
-
78651548792
-
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications
-
López-Novoa JM, Rodríguez-Peña AB, Ortiz A, Martínez-Salgado C, Hernández FJL. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med. 2011; 9:13.
-
(2011)
J Transl Med
, vol.9
, pp. 13
-
-
López-Novoa, J.M.1
Rodríguez-Peña, A.B.2
Ortiz, A.3
Martínez-Salgado, C.4
Hernández, F.J.L.5
-
66
-
-
79958737849
-
Oxidative stress and autonomic nervous system functions in restless legs syndrome
-
Cikrikcioglu MA, Hursitoglu M, Erkal H, et al. Oxidative stress and autonomic nervous system functions in restless legs syndrome. Eur J Clin Invest. 2011; 41:734–742.
-
(2011)
Eur J Clin Invest
, vol.41
, pp. 734-742
-
-
Cikrikcioglu, M.A.1
Hursitoglu, M.2
Erkal, H.3
-
67
-
-
84866497986
-
Oxidative stress in the brain causes hypertension via sympathoexcitation
-
Kishi T, Hirooka Y. Oxidative stress in the brain causes hypertension via sympathoexcitation. Front Physiol. 2012; 3.
-
(2012)
Front Physiol
, vol.3
-
-
Kishi, T.1
Hirooka, Y.2
-
68
-
-
79960810124
-
ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function
-
Xia H, Suda S, Bindom S, et al. ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS ONE. 2011; 6:e22682.
-
(2011)
PLoS ONE
, vol.6
-
-
Xia, H.1
Suda, S.2
Bindom, S.3
-
69
-
-
85055634117
-
Reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension by modulating paraventricular nucleus of hypothalamuseditor
-
Nishihara M, Hirooka Y, Matsukawa R, Ito K, Kishi T, Sunagawa K. Reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension by modulating paraventricular nucleus of hypothalamuseditor. Circulation. 2010; 122:A16022.
-
(2010)
Circulation
, vol.122
, pp. A16022
-
-
Nishihara, M.1
Hirooka, Y.2
Matsukawa, R.3
Ito, K.4
Kishi, T.5
Sunagawa, K.6
-
70
-
-
2442706556
-
Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats
-
Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation. 2004; 109:2357–2362.
-
(2004)
Circulation
, vol.109
, pp. 2357-2362
-
-
Kishi, T.1
Hirooka, Y.2
Kimura, Y.3
Ito, K.4
Shimokawa, H.5
Takeshita, A.6
-
71
-
-
61849153939
-
Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension
-
Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation. 2009; 119:978–986.
-
(2009)
Circulation
, vol.119
, pp. 978-986
-
-
Nagae, A.1
Fujita, M.2
Kawarazaki, H.3
Matsui, H.4
Ando, K.5
Fujita, T.6
-
72
-
-
70449419111
-
Anti-atherosclerotic molecules targeting oxidative stress and inflammation
-
Adameova A, Xu Y, Duhamel T, Tappia P, Shan L, Dhalla N. Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr Pharm Des. 2009; 15:3094–3107.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 3094-3107
-
-
Adameova, A.1
Xu, Y.2
Duhamel, T.3
Tappia, P.4
Shan, L.5
Dhalla, N.6
-
73
-
-
0031024650
-
The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms
-
Wolf G, Ziyadeh FN. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis. 1997; 29:153–163.
-
(1997)
Am J Kidney Dis
, vol.29
, pp. 153-163
-
-
Wolf, G.1
Ziyadeh, F.N.2
-
74
-
-
0022503155
-
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
-
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986; 77:1925.
-
(1986)
J Clin Invest
, vol.77
, pp. 1925
-
-
Zatz, R.1
Dunn, B.R.2
Meyer, T.W.3
Anderson, S.4
Rennke, H.G.5
Brenner, B.M.6
-
75
-
-
0036324130
-
High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells
-
Hsieh T-J, Zhang S-L, Filep JG, Tang S-S, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology. 2002; 143:2975–2985.
-
(2002)
Endocrinology
, vol.143
, pp. 2975-2985
-
-
Hsieh, T.-J.1
Zhang, S.-L.2
Filep, J.G.3
Tang, S.-S.4
Ingelfinger, J.R.5
Chan, J.S.6
-
76
-
-
0032913340
-
Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells
-
Zhang S-L, Filep JG, Hohman TC, Tang S-S, Ingelfinger JR, Chan JS. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int. 1999; 55:454–464.
-
(1999)
Kidney Int
, vol.55
, pp. 454-464
-
-
Zhang, S.-L.1
Filep, J.G.2
Hohman, T.C.3
Tang, S.-S.4
Ingelfinger, J.R.5
Chan, J.S.6
-
77
-
-
0034522676
-
High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells
-
Zhang S-L, Tang S-S, Chen X, Filep JG, Ingelfinger JR, Chan JS. High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells. Endocrinology. 2000; 141:4637–4646.
-
(2000)
Endocrinology
, vol.141
, pp. 4637-4646
-
-
Zhang, S.-L.1
Tang, S.-S.2
Chen, X.3
Filep, J.G.4
Ingelfinger, J.R.5
Chan, J.S.6
-
78
-
-
84945923152
-
Tumor necrosis factor-alpha is essential for angiotensin II-induced ventricular remodeling: role for oxidative stress
-
Sriramula S, Francis J. Tumor necrosis factor-alpha is essential for angiotensin II-induced ventricular remodeling: role for oxidative stress. PLoS ONE. 2015; 10:e0138372.
-
(2015)
PLoS ONE
, vol.10
-
-
Sriramula, S.1
Francis, J.2
-
79
-
-
84978816860
-
Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence
-
Tsai I-C, Pan Z-c, Cheng H-P, Liu C-H, Lin B-T, Jiang MJ. Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence. J Mol Cell Cardiol. 2016; 98:18–27.
-
(2016)
J Mol Cell Cardiol
, vol.98
, pp. 18-27
-
-
Tsai, I.-C.1
Pan, Z.-C.2
Cheng, H.-P.3
Liu, C.-H.4
Lin, B.-T.5
Jiang, M.J.6
-
80
-
-
84907574430
-
Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways
-
Zhang X, Wu M, Jiang H, et al. Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways. PLoS ONE. 2014; 9:e107634.
-
(2014)
PLoS ONE
, vol.9
-
-
Zhang, X.1
Wu, M.2
Jiang, H.3
-
81
-
-
0027954494
-
Free radicals in biology: oxidative stress and the effects of ionizing radiation
-
Riley P. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 1994; 65:27–33.
-
(1994)
Int J Radiat Biol
, vol.65
, pp. 27-33
-
-
Riley, P.1
-
83
-
-
16844363759
-
Role of oxidative stress in diabetic nephropathy
-
Vasavada N, Agarwal R. Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis. 2005; 12:146–154.
-
(2005)
Adv Chronic Kidney Dis
, vol.12
, pp. 146-154
-
-
Vasavada, N.1
Agarwal, R.2
|